Healthcare contracts from National Cancer Institute

Building Robust Open-Source Software Applications for the Identification, Prioritization, Visualization, and Selection of Neoantigens in Cancer ImmunotherapyNew

administrativeGrant

Buyer: National Cancer Institute
Jurisdiction: MO
Response due: —
Value: $155,500

Federal

it-services

Nih-reporter · indexed 8 hours ago

Ultrahigh-Throughput Cell Interaction Screening to Advance CAR-T Therapeutic DevelopmentNew

administrativeGrantRecompete

Buyer: National Cancer Institute
Jurisdiction: CA
Response due: —
Value: $306,872

Federal

Nih-reporter · indexed 8 hours ago

Cancer Biology Training ProgramNew

administrativeGrantRecompete

Buyer: National Cancer Institute
Jurisdiction: TX
Response due: —
Value: $240,459

Federal

Nih-reporter · indexed 8 hours ago

Tumor suppressor vulnerability conferred by aneuploid loss of haploinsufficient metallothionein genesNew

administrativeGrantRecompete

Buyer: National Cancer Institute
Jurisdiction: SC
Response due: —
Value: $9,890

Federal

Nih-reporter · indexed 8 hours ago

TGF-Beta 3 in Mammary Involution and Post-Partum Breast CancerNew

administrativeGrant

Buyer: National Cancer Institute
Jurisdiction: CT
Response due: —
Value: $539,633

Federal

Nih-reporter · indexed 8 hours ago

Volumetric histopathology of surgical specimens: scalable 3D analysis in breast and prostate cancerNew

clinicalGrant

Buyer: National Cancer Institute
Jurisdiction: MA
Response due: —
Value: $141,864

Federal

Nih-reporter · indexed 8 hours ago

Increasing Access and Participation to Early Phase Clinical TrialsNew

clinicalGrant

Buyer: National Cancer Institute
Jurisdiction: KS
Response due: —
Value: $159,574

Federal

Nih-reporter · indexed 8 hours ago

Disrupting MDSC-fibroblast interactions to overcome chemoimmunotherapy resistance in pancreatic cancerNew

administrativeGrant

Buyer: National Cancer Institute
Jurisdiction: FL
Response due: —
Value: $351,131

Federal

Nih-reporter · indexed 8 hours ago

Microfluidic isolation and molecular analysis of circulating tumor cells for the study of neuroendocrine transdifferentiation in prostate cancerNew

administrativeGrantRecompete

Buyer: National Cancer Institute
Jurisdiction: MA
Response due: —
Value: $629,106

Federal

Nih-reporter · indexed 8 hours ago

Randomized Trial of Exercise Therapy on Markers of Progression in Localized Prostate CancerNew

administrativeGrantRecompete

Buyer: National Cancer Institute
Jurisdiction: CA
Response due: —
Value: $752,423

Federal

Nih-reporter · indexed 8 hours ago

Targeting PLK1 signaling for the treatment of fibrolamellar carcinomaNew

administrativeGrant

Buyer: National Cancer Institute
Jurisdiction: WA
Response due: —
Value: $473,280

Federal

Nih-reporter · indexed 8 hours ago

Acupuncture for Cognitive Health in Older Survivors of Prostate Cancer (ACHIEVE)New

administrativeGrantRecompete

Buyer: National Cancer Institute
Jurisdiction: NY
Response due: —
Value: $242,997

Federal

Nih-reporter · indexed 8 hours ago

Deciphering tumor-immune coevolution during metastatic progressionNew

administrativeGrant

Buyer: National Cancer Institute
Jurisdiction: CA
Response due: —
Value: $605,108

Federal

Nih-reporter · indexed 8 hours ago

Correlating Genotype and Phenotype of Metastatic Cancer Cells In Vivo Using Nanolaser Optical BarcodeNew

administrativeGrant

Buyer: National Cancer Institute
Jurisdiction: TX
Response due: —
Value: $23,525

Federal

Nih-reporter · indexed 8 hours ago

Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approachNew

administrativeGrant

Buyer: National Cancer Institute
Jurisdiction: MA
Response due: —
Value: $126,580

Federal

Nih-reporter · indexed 8 hours ago

Keratinocyte signaling mediates neuropathic painNew

administrativeGrant

Buyer: National Cancer Institute
Jurisdiction: WI
Response due: —
Value: $647,147

Federal

Nih-reporter · indexed 8 hours ago

Kinase Signaling in Epidermal Homeostasis and Early NeoplasiaNew

administrativeGrant

Buyer: National Cancer Institute
Jurisdiction: VA
Response due: —
Value: $494,181

Federal

Nih-reporter · indexed 8 hours ago

Targeting Perp in PDAC tumor and cancer cachexiaNew

administrativeGrant

Buyer: National Cancer Institute
Jurisdiction: NC
Response due: —
Value: $155,518

Federal

Nih-reporter · indexed 8 hours ago

Targeting tumor innate immune signaling in pancreatic cancerNew

administrativeGrant

Buyer: National Cancer Institute
Jurisdiction: MO
Response due: —
Value: $398,522

Federal

Nih-reporter · indexed 8 hours ago

Improving Care Delivery for Individuals with Mental Illness and Cancer Across a Cancer Center Network.New

administrativeGrant

Buyer: National Cancer Institute
Jurisdiction: MA
Response due: —
Value: $662,135

Federal

Nih-reporter · indexed 8 hours ago

National Cancer Institute

Recent contracts

Building Robust Open-Source Software Applications for the Identification, Prioritization, Visualization, and Selection of Neoantigens in Cancer ImmunotherapyNew

Ultrahigh-Throughput Cell Interaction Screening to Advance CAR-T Therapeutic DevelopmentNew

Cancer Biology Training ProgramNew

Who is this buyer

Organization

Buying history

What they buy

Financial highlights

Who holds their work today

What they're trying to solve

Ways to meet this buyer

Upcoming

Past

Building Robust Open-Source Software Applications for the Identification, Prioritization, Visualization, and Selection of Neoantigens in Cancer ImmunotherapyNew

Ultrahigh-Throughput Cell Interaction Screening to Advance CAR-T Therapeutic DevelopmentNew

Cancer Biology Training ProgramNew

Tumor suppressor vulnerability conferred by aneuploid loss of haploinsufficient metallothionein genesNew

TGF-Beta 3 in Mammary Involution and Post-Partum Breast CancerNew

Volumetric histopathology of surgical specimens: scalable 3D analysis in breast and prostate cancerNew

Increasing Access and Participation to Early Phase Clinical TrialsNew

Disrupting MDSC-fibroblast interactions to overcome chemoimmunotherapy resistance in pancreatic cancerNew

Microfluidic isolation and molecular analysis of circulating tumor cells for the study of neuroendocrine transdifferentiation in prostate cancerNew

Randomized Trial of Exercise Therapy on Markers of Progression in Localized Prostate CancerNew

Targeting PLK1 signaling for the treatment of fibrolamellar carcinomaNew

Acupuncture for Cognitive Health in Older Survivors of Prostate Cancer (ACHIEVE)New

Deciphering tumor-immune coevolution during metastatic progressionNew

Correlating Genotype and Phenotype of Metastatic Cancer Cells In Vivo Using Nanolaser Optical BarcodeNew

Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approachNew

Keratinocyte signaling mediates neuropathic painNew

Kinase Signaling in Epidermal Homeostasis and Early NeoplasiaNew

Targeting Perp in PDAC tumor and cancer cachexiaNew

Targeting tumor innate immune signaling in pancreatic cancerNew

Improving Care Delivery for Individuals with Mental Illness and Cancer Across a Cancer Center Network.New

Sectors they buy

Agencies issuing

Where they buy

Common themes